APA

Lambertini M., Poggio F., Bruzzone M., Conte B., Bighin C., de Azambuja E., Giuliano M., De Laurentiis M., Cognetti F., Fabi A., Bisagni G., Durando A., Turletti A., Urracci Y., Garrone O., Puglisi F., Montemurro F., Ceppi M. & Del Mastro L. (20210317). Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. : International journal of cancer.

Chicago

Lambertini Matteo, Poggio Francesca, Bruzzone Marco, Conte Benedetta, Bighin Claudia, de Azambuja Evandro, Giuliano Mario, De Laurentiis Michele, Cognetti Francesco, Fabi Alessandra, Bisagni Giancarlo, Durando Antonio, Turletti Anna, Urracci Ylenia, Garrone Ornella, Puglisi Fabio, Montemurro Filippo, Ceppi Marcello and Del Mastro Lucia. 20210317. Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. : International journal of cancer.

Harvard

Lambertini M., Poggio F., Bruzzone M., Conte B., Bighin C., de Azambuja E., Giuliano M., De Laurentiis M., Cognetti F., Fabi A., Bisagni G., Durando A., Turletti A., Urracci Y., Garrone O., Puglisi F., Montemurro F., Ceppi M. and Del Mastro L. (20210317). Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. : International journal of cancer.

MLA

Lambertini Matteo, Poggio Francesca, Bruzzone Marco, Conte Benedetta, Bighin Claudia, de Azambuja Evandro, Giuliano Mario, De Laurentiis Michele, Cognetti Francesco, Fabi Alessandra, Bisagni Giancarlo, Durando Antonio, Turletti Anna, Urracci Ylenia, Garrone Ornella, Puglisi Fabio, Montemurro Filippo, Ceppi Marcello and Del Mastro Lucia. Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. : International journal of cancer. 20210317.